Majem, M., R. Álvarez, A. L. Ortega, L. Ruiz de Alda, R. Gordo, J. F. García, Y. Ivanova-Markova, A. González-Domínguez, R. Sánchez San Cristóbal, and F. Rojo. “Cost-Benefit Analysis of ALK Diagnosis Vs. Non-Diagnosis in Patients With Advanced non–small Cell Lung Cancer in Spain”. Global and Regional Health Technology Assessment, vol. 9, no. 1, Sept. 2022, pp. 82-90, doi:10.33393/grhta.2022.2449.